24 min
It’s In Our Genes: The Potential of Gene Therapy with Dr. Peter Marks Science with a Twist
-
- Ciências naturais
In this episode of Science with a Twist, Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA, joins host Dr. Timothy Miller to dive into the complexities and promise of gene therapy. They discuss the potential of gene therapy to revolutionize medicine, narrowing in on the scientific progress made and recent advancements in treating patients and families with Rare Diseases. Dr. Marks shares insights on the FDA's role in ensuring safety and efficacy, emphasizing the importance of collaboration between regulatory bodies, researchers, and developers. Efforts related to the profround work of the public/private partnerships funding the Accelerating Medicines Partnerships Bespoke Gene Therapy Consotritum are also highlighted.
The conversation also explores the many challenges of bringing the promise of gene therapies to patients, including, cost, accessibility, and ethical considerations. Dr. Marks outlines the FDA's efforts to streamline the approval process while maintaining rigorous standards, highlighting the careful balance between innovation and patient safety.
Finally, the episode touches on the future of gene and genetic therapies, with Dr. Marks expressing optimism about their ability to treat previously incurable diseases as well as common, everyday conditions. He stresses the importance of public education and engagement to navigate the complexities of these new treatments and higlights the need for industry partners like Thermo Fishing in empowering the science thru applying novel creativity and innovaiton. The episode provides a comprehensive overview of gene therapy's current state and its promising future.
In this episode of Science with a Twist, Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA, joins host Dr. Timothy Miller to dive into the complexities and promise of gene therapy. They discuss the potential of gene therapy to revolutionize medicine, narrowing in on the scientific progress made and recent advancements in treating patients and families with Rare Diseases. Dr. Marks shares insights on the FDA's role in ensuring safety and efficacy, emphasizing the importance of collaboration between regulatory bodies, researchers, and developers. Efforts related to the profround work of the public/private partnerships funding the Accelerating Medicines Partnerships Bespoke Gene Therapy Consotritum are also highlighted.
The conversation also explores the many challenges of bringing the promise of gene therapies to patients, including, cost, accessibility, and ethical considerations. Dr. Marks outlines the FDA's efforts to streamline the approval process while maintaining rigorous standards, highlighting the careful balance between innovation and patient safety.
Finally, the episode touches on the future of gene and genetic therapies, with Dr. Marks expressing optimism about their ability to treat previously incurable diseases as well as common, everyday conditions. He stresses the importance of public education and engagement to navigate the complexities of these new treatments and higlights the need for industry partners like Thermo Fishing in empowering the science thru applying novel creativity and innovaiton. The episode provides a comprehensive overview of gene therapy's current state and its promising future.
24 min